PA
XENE icon

Perceptive Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.28M Sell
200,791
-124,533
-38% -$3.9M 0.23% 60
2025
Q1
$10.9M Hold
325,324
0.39% 49
2024
Q4
$12.8M Sell
325,324
-199,606
-38% -$7.82M 0.35% 52
2024
Q3
$20.7M Sell
524,930
-58,326
-10% -$2.3M 0.44% 56
2024
Q2
$22.7M Sell
583,256
-308,952
-35% -$12M 0.55% 51
2024
Q1
$38.4M Sell
892,208
-208,540
-19% -$8.98M 0.67% 48
2023
Q4
$50.7M Buy
1,100,748
+483,248
+78% +$22.3M 1.13% 29
2023
Q3
$21.1M Sell
617,500
-605,877
-50% -$20.7M 0.7% 42
2023
Q2
$47.1M Sell
1,223,377
-608,797
-33% -$23.4M 1.36% 21
2023
Q1
$65.6M Sell
1,832,174
-89,099
-5% -$3.19M 1.94% 12
2022
Q4
$75.8M Sell
1,921,273
-201,262
-9% -$7.94M 2.13% 14
2022
Q3
$76.6M Hold
2,122,535
2.22% 14
2022
Q2
$64.6M Sell
2,122,535
-288,912
-12% -$8.79M 2.02% 11
2022
Q1
$73.7M Hold
2,411,447
1.48% 19
2021
Q4
$75.3M Buy
2,411,447
+389,396
+19% +$12.2M 1.16% 22
2021
Q3
$30.9M Buy
2,022,051
+343,078
+20% +$5.24M 0.45% 55
2021
Q2
$31.3M Buy
1,678,973
+1,163,931
+226% +$21.7M 0.41% 56
2021
Q1
$9.22M Buy
+515,042
New +$9.22M 0.12% 100
2017
Q3
Sell
-723,853
Closed -$2.28M 147
2017
Q2
$2.28M Hold
723,853
0.11% 75
2017
Q1
$2.9M Sell
723,853
-16,419
-2% -$65.7K 0.16% 76
2016
Q4
$5.7M Sell
740,272
-22,528
-3% -$173K 0.41% 55
2016
Q3
$6.18M Buy
762,800
+330,000
+76% +$2.67M 0.4% 59
2016
Q2
$2.55M Buy
432,800
+227,000
+110% +$1.34M 0.18% 73
2016
Q1
$1.44M Hold
205,800
0.13% 88
2015
Q4
$1.66M Hold
205,800
0.12% 75
2015
Q3
$1.7M Sell
205,800
-19,200
-9% -$159K 0.14% 71
2015
Q2
$2.59M Hold
225,000
0.16% 80
2015
Q1
$3.8M Hold
225,000
0.29% 58
2014
Q4
$4.44M Buy
+225,000
New +$4.44M 0.37% 53